Loading…
Mineralocorticoid·Endocrinology - Systemic Corticosteroids
Mineralocorticoid replacement in Addison's disease, salt-losing adrenogenital syndrome
No source link confirmed for this record yet. Its own source notes are under Additional.
Max Dose
0.3 mg/day
Half-life
18-36 h
High risk: Hypokalemia
CRITICAL RISK
Fluid Retention
POTENT
Avoid / Cautions
Uncontrolled hypertension, congestive heart failure.
Overview
A purely synthetic mineralocorticoid. Has virtually zero anti-inflammatory effect but is incredibly potent at retaining sodium and water. Acts as a synthetic aldosterone.
Clinical Focus
Drastically dumps potassium into the urine. Hypokalemia is virtually guaranteed without monitoring or dietary adjustments.
Bottom Line
Fludrocortisone is the only available mineralocorticoid for adrenal insufficiency and orthostatic hypotension, but causes sodium retention and hypokalaemia requiring electrolyte monitoring.
Brand Names
Florinef
Oral Routes
Tablets (0.1 mg = 100 mcg). MUST be kept refrigerated.
Prescribing & PBS
Authority Required (PBS).
Primary
Mineralocorticoid replacement in Addison's disease, salt-losing adrenogenital syndrome.
Off-Label
Severe refractory orthostatic hypotension, POTS.
Clinical Place
Mandatory daily life-support drug for patients whose adrenal glands are destroyed (Addison's) and cannot make aldosterone.
No calculator, monitoring schedule or factsheet is linked to this medicine page yet.